Skip to main content

BPCI Advanced Model Extension

Doctor with stethoscope, notes and calculator

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model. 

  • The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025. 
  • New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7. 
  • New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that:
    • the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%; 
    • the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%;
    • the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital outpatient setting. All episodes under this clinical episode category will include additional adjustments to account for trauma and fractures; and
    • episodes that co-occur with a COVID-19 diagnosis will no longer be excluded from the model; however, the pricing methodology will include risk adjustment for when a beneficiary has a COVID-19 diagnosis during the episode. 

What do these changes mean for the BPCIA model?

Enrollment in the BPCIA model has declined over the last several years due to the expansion of risk to entire clinical episode service line groups and complex pricing methodology changes making financial goals more difficult to attain. These challenges have included the exit of major large conveners and their cohorts of downstream episode initiators. Under the new two-year extension, providers that previously participated in BPCIA will have the opportunity to reapply and providers who have not yet participated will have an opportunity to get involved. BPCIA has not had an open enrollment period since Model Year 3 in 2019 (calendar year 2020). 

New pricing methodology changes are a step in the right direction to retain enrollment of existing providers and encourage the application of non-participating providers. These changes will favor participants by reducing uncertainty in target prices, particularly as it concerns the Peer Group Trend Factor Adjustment. The inclusion of episodes when a beneficiary has a COVID-19 diagnosis will boost episode volume. It also includes fair additional risk adjustment to account for changes in episode expenditures due to the presence of a COVID-19 diagnosis. In addition, participants currently at risk for medical clinical episode categories will have higher target prices. 

There have been growing concerns about CMS’ ability to evaluate the effectiveness of this model since substantial changes in participation may result in selection bias. CMS will be able to better evaluate the impact of BPCIA by making these changes. 

What should providers do in the interim?

Current model participants can evaluate the impact of these changes compared to prior model years when evaluating their upcoming new baseline data and as Model Year 6 commences. 

Providers not currently enrolled in BPCIA should look for an announcement requesting applications from CMS in early 2023 for their chance to apply for the extension period. 

DataGen has the expertise to help providers evaluate opportunities under bundled payment arrangements and supports providers with their data analysis needs throughout the performance period. Contact us to learn more. 


Popular posts from this blog

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit

You’ve been accepted to the Enhancing Oncology Model. Now what?

The Centers for Medicare and Medicaid Services Innovation Center recently announced approved applicants for the new Enhancing Oncology Model. If your facility has been selected by CMS, are you still weighing your options during the current baseline evaluation period?  Two deciding factors may include the program data that CMS provides and whether EOM is enough of an improvement over the prior Oncology Care Model to make your investment worthwhile. Another factor to consider: Will you have the resources in place to conduct a baseline evaluation before EOM’s program start on July 1, 2023? How EOM differs from OCM EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment. It includes three major updates: Fewer cancer types. Compared with OCM’s 21, EOM will be limited to seven common cancer types: breast, prostate, lung, small intestine/colorectal, multiple myeloma, lymphoma and chronic le